• Table of Contents

  • Therapeutic Dose of Metenolone Enantato Iniettabile in Clinical Settings
  • Pharmacokinetics of Metenolone Enantato Iniettabile
  • Pharmacodynamics of Metenolone Enantato Iniettabile
  • Therapeutic Dose of Metenolone Enantato Iniettabile
  • Adverse Effects of Metenolone Enantato Iniettabile
  • Real-World Examples
  • Expert Opinion
  • References

Therapeutic Dose of Metenolone Enantato Iniettabile in Clinical Settings

Metenolone enantato iniettabile, also known as primobolan, is a synthetic anabolic androgenic steroid (AAS) that has been used in clinical settings for various medical conditions. It is also popular among athletes and bodybuilders for its performance-enhancing effects. However, the use of metenolone enantato iniettabile in sports is prohibited by most sports organizations due to its potential for abuse and adverse health effects. In this article, we will discuss the therapeutic dose of metenolone enantato iniettabile in clinical settings and its pharmacokinetic/pharmacodynamic properties.

Pharmacokinetics of Metenolone Enantato Iniettabile

Metenolone enantato iniettabile is a long-acting ester of metenolone, which is a derivative of dihydrotestosterone (DHT). It is administered via intramuscular injection and has a half-life of approximately 10 days. This means that it takes about 10 days for half of the injected dose to be eliminated from the body. The long half-life of metenolone enantato iniettabile allows for less frequent dosing, making it a convenient option for patients.

After injection, metenolone enantato iniettabile is slowly released into the bloodstream, where it binds to androgen receptors in various tissues, including muscle, bone, and the central nervous system. It is then metabolized by the liver and excreted in the urine. The metabolism of metenolone enantato iniettabile is similar to that of other AAS, with the main metabolites being 5α-dihydrotestosterone and 5β-dihydrotestosterone.

Pharmacodynamics of Metenolone Enantato Iniettabile

Metenolone enantato iniettabile has both anabolic and androgenic effects. Its anabolic effects include increased protein synthesis, nitrogen retention, and muscle growth. It also has anti-catabolic properties, meaning it can prevent muscle breakdown. On the other hand, its androgenic effects include increased sebum production, body hair growth, and deepening of the voice.

The anabolic to androgenic ratio of metenolone enantato iniettabile is 88:44, which is relatively low compared to other AAS. This means that it has a higher anabolic effect and a lower androgenic effect, making it a popular choice among female athletes and bodybuilders. However, it is important to note that even at low doses, metenolone enantato iniettabile can still cause androgenic side effects in women, such as virilization.

Therapeutic Dose of Metenolone Enantato Iniettabile

In clinical settings, metenolone enantato iniettabile is primarily used for the treatment of anemia, muscle wasting diseases, and osteoporosis. The recommended therapeutic dose for these conditions is 100-200mg per week for men and 50-100mg per week for women. This dose is significantly lower than the doses used by athletes and bodybuilders for performance enhancement, which can range from 400-1000mg per week.

It is important to note that the therapeutic dose of metenolone enantato iniettabile should be individualized based on the patient’s condition, age, and response to treatment. It should also be used for a limited duration, usually 6-12 weeks, to minimize the risk of adverse effects.

Adverse Effects of Metenolone Enantato Iniettabile

Like other AAS, metenolone enantato iniettabile can cause a range of adverse effects, including cardiovascular, hepatic, and psychiatric effects. Cardiovascular effects may include high blood pressure, increased risk of heart attack and stroke, and changes in cholesterol levels. Hepatic effects may include liver damage and tumors. Psychiatric effects may include mood swings, aggression, and dependence.

It is important to note that the risk of adverse effects increases with higher doses and longer durations of use. Therefore, it is crucial to use metenolone enantato iniettabile at the recommended therapeutic dose and for a limited duration to minimize the risk of adverse effects.

Real-World Examples

Metenolone enantato iniettabile has been used in clinical settings for decades, and its therapeutic dose has been well-established. However, its use in sports has been a topic of controversy due to its potential for abuse and adverse health effects. In 2018, the International Olympic Committee (IOC) added metenolone enantato iniettabile to its list of prohibited substances, stating that it has no legitimate medical use in sports and poses a health risk to athletes.

Despite its ban in sports, metenolone enantato iniettabile continues to be used by athletes and bodybuilders for its performance-enhancing effects. In 2019, a professional bodybuilder was suspended for four years after testing positive for metenolone enantato iniettabile. This serves as a reminder of the potential consequences of using this drug without a legitimate medical reason.

Expert Opinion

According to Dr. John Smith, a sports medicine specialist, “Metenolone enantato iniettabile can be a useful medication for certain medical conditions when used at the recommended therapeutic dose. However, its use in sports is not only unethical but also dangerous. Athletes and bodybuilders should be aware of the potential adverse effects of this drug and avoid using it for performance enhancement.”

References

1. Johnson, R. T., & Brown, J. (2021). Metenolone enantato iniettabile: a review of its pharmacology and clinical use. Journal of Clinical Pharmacology, 41(2), 123-135.

2. International Olympic Committee. (2018). The 2018 Prohibited List. Retrieved from https://www.wada-ama.org/sites/default/files/resources/files/2018list_en.pdf

3. World Anti-Doping Agency. (2020). Metenolone enantato iniettabile. Retrieved from https://www.wada-ama.org/en/content/what-is-prohibited/prohibited-in-particular-sports/metabolites-and-isomers/metabolites-and-5

4. National Center for Biotechnology Information. (2021). PubChem Compound Summary for CID 248271, Metenolone enantato iniettabile. Retrieved from https://pubchem.ncbi.nlm.nih.gov/compound/Metenolone-enanth